About bsbh

This author has not yet filled in any details.
So far bsbh has created 194 blog entries.

Qasim Rafiq

Qasim Rafiq Senior Lecturer (Assistant Professor) Bioprocessing of Regenerative, Cellular and Gene Therapies, UCL I am currently a Lecturer (Assistant Professor) in Bioprocess Engineering at Aston University with a specific research focus on the manufacture, translation and commercialisation of cell, gene and tissue-based therapies. In my first 12 months as a Lecturer, I [...]

Qasim Rafiq2017-08-09T09:15:00+00:00

James McBlane

James McBlane CAT Member, Preclinical Assessor, UK Medicines and Healthcare Products Regulatory Agency (MHRA) After degrees in pharmacology at Dundee and Aston universities, Dr McBlane worked for Wellcome and then at the UK Medicines Control Agency before moving to the Japanese biopharmaceutical company, Chugai, for 10 years, latterly specialising in preclinical development.  He [...]

James McBlane2017-08-09T09:15:00+00:00

Andrew Plump

Andrew Plump, M.D., Ph.D. Chief Medical and Scientific Officer, Takeda In 2015, Andrew Plump, M.D., Ph.D., joined Takeda as Chief Medical and Scientific Officer (CMSO). Dr. Plump also serves as a member of Takeda’s Executive Team and of the company’s Board of Directors. In his position, he leads Takeda’s global Research & Development [...]

Andrew Plump2017-08-09T09:15:00+00:00

Keith Thompson

Keith Thompson CEO, Cell and Gene Therapy Catapult Keith has established a team of over 120 cell and gene therapy experts in state-of-the-art laboratories in London and is now building a large-scale manufacturing centre. Keith joined the Cell and Gene Therapy Catapult from the Scottish Blood Transfusion Service where he was National Director, [...]

Keith Thompson2017-08-09T09:15:00+00:00

Eduardo Bravo

Eduardo Bravo Founder and Chief Executive Officer, TiGenix President, EBE Prior to joining TiGenix in 2005, Eduardo held several senior management and commercial positions at Sanofi-Aventis and SmithKline Beecham, lastly as Vice President for Latin America for Sanofi-Aventis. He holds a degree in Business Administration and an MBA from INSEAD. Eduardo is President [...]

Eduardo Bravo2017-08-09T09:15:00+00:00

Seigo Izumo

Seigo Izumo, MD Senior Vice President, Global Head of Regenerative Medicine Unit & Head of Scientific Affairs Japan, Takeda Pharmaceutical Company Ltd. Dr. Seigo Izumo is Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs Japan at Takeda Pharmaceutical Company. He is responsible for Takeda’s strategic initiative [...]

Seigo Izumo2017-11-02T08:22:50+00:00

Advanced Therapies – Opportunities and Challenges – Speakers

Organised in partnership with: Advanced Therapies – Opportunities and Challenges 14th November, London Speakers Richard Barker Founding Director, Centre for the Advancement of Sustainable Medical Innovation (CASMI) Biography Steve Bates Chief Executive Officer, [...]

Advanced Therapies – Opportunities and Challenges – Speakers2017-11-21T15:08:51+00:00

Advanced Therapies – Opportunities and Challenges – Venue

Organised in partnership with: Advanced Therapies – Opportunities and Challenges 14th November, London Conference BMA House Tavistock Square, Bloomsbury, London WC1H 9JP Directions: http://www.bmahouse.org.uk/contact-or-find-us Need a hotel? We don't have an [...]

Advanced Therapies – Opportunities and Challenges – Venue2017-11-21T15:08:11+00:00

Advanced Therapies – Opportunities and Challenges – Agenda

Organised in partnership with: Advanced Therapies – Opportunities and Challenges 14th November, London Agenda: 14 November 2017 - British Medical Association, London 8:30 Registration 9:00 Introduction by Conference Host, Seigo Izumo, Senior Vice President for Regenerative Medicine, Takeda [...]

Advanced Therapies – Opportunities and Challenges – Agenda2017-11-21T15:07:35+00:00